🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This study is the first administration of GSK610677 to man. The main aim of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-26
Trial ID
NCT00694902
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Scientia Clinical Research
Start Date
2020-11-25
Trial ID
NCT04629131
This study described in the present protocol consists of two sections. Part...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-20
Trial ID
NCT01381419
Treatments Being Tested
To evaluate the safety and tolerability of multiple doses of PF 02545920 ad...
Status
Completed
Location
California Clinical Trials Medical Group
Start Date
2013-03-06
Trial ID
NCT01829048
Treatments Being Tested
First-in-human, single centre, two parts, dose-escalation, parallel-group, ...
Status
Recruiting
Location
CROSS Research S.A. Phase I Unit
Start Date
2024-12-04
Trial ID
NCT06705998
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
This study will be the first administration of CCI15106 capsules for inhala...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-02-10
Trial ID
NCT03243760
Treatments Being Tested
The purpose of this study is to obtain evidence of the safety of NNZ-2566 i...
Status
Completed
Location
Nucleus Network
Start Date
2010-03
Trial ID
NCT00961779
This is a phase 1, first-in-human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2021-09-27
Trial ID
NCT05112159